LCM
TECH icon

Logan Capital Management’s Bio-Techne TECH Stock Holding History

Logan Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-80
Closed -$5.93K – 502
2023
Q1 		$5.93K Hold
80
– – ﹤0.01% 430
2022
Q4 		$6.63K Sell
80
-80
-50% -$6.35K ﹤0.01% 451
2022
Q3 		$11K Buy
+160
New +$13.8K ﹤0.01% 422

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DDC
DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Logan Capital Management's TECH Position: Q2 2023 in Review

Logan Capital Management sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 80 shares — an estimated $5.93K sold.

Logan Capital Management first reported a position in TECH in Q3 2022 and held it in 3 quarters. The position peaked at $11K in Q3 2022. 528 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

  • Logan Capital Management reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
  • Logan Capital Management sold 80 Bio-Techne shares in Q2 2023, an estimated $5.93K.
  • Logan Capital Management first reported a position in Bio-Techne in Q3 2022 and held it in 3 quarters.
  • Logan Capital Management's Bio-Techne position peaked at $11K in Q3 2022.
  • 528 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Logan Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.